FIELD: medicine.
SUBSTANCE: sodium/iodine symporter expression on a tumour cell membrane is measured in a tumour material taken by fine-needle aspiration biopsy, and if the measured expression is less than 1%, surgery is supposed to be added with the central lymph node dissection. The sodium/iodine symporter expression on the tumour cell membrane is determined by flow cytometry.
EFFECT: on the ground of the preoperative determination of the sodium/iodine symporter expression on the tumour cell membrane, the method enables establishing the extent of surgery for high-differentiated thyroid carcinoma, papillary and follicular, reliably.
2 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREOPERATIVE DETERMINATION OF VOLUME OF SURGICAL TREATMENT OF HIGH-DIFFERENTIATED THYROID CANCER | 2018 |
|
RU2709140C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF THYROID NEOPLASMS | 2019 |
|
RU2705110C1 |
| METHOD FOR COMPLEX PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULES OF THE THYROID GLAND | 2022 |
|
RU2805941C1 |
| METHOD FOR PREDICTION OF RECURRENT THYROID CANCER AFTER RADICAL SURGERY | 2024 |
|
RU2823255C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF NODULAR FORMATIONS OF THE HUMAN THYROID GLAND | 2021 |
|
RU2757347C1 |
| METHOD FOR DETERMINING THERAPEUTIC APPROACH TO DIFFERENTIATED THYROID CARCINOMA COMBINED WITH HASHIMOTO'S THYROIDITIS WITH JUNCTION | 2013 |
|
RU2522388C1 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO THYROID NODULES | 2023 |
|
RU2823767C1 |
| METHOD OF DETERMINING RISK OF DEVELOPING PAPILLARY THYROID CANCER | 2023 |
|
RU2807880C1 |
| METHOD FOR SURGICAL TREATMENT OF THYROID CANCER IN THYROTOXICOSIS | 2020 |
|
RU2751971C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INDIVIDUAL'S THYROID NEW GROWTHS | 2014 |
|
RU2569154C1 |
